|
Index of reports
> Cases resulting in death (34)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in death.
Reports 1 - 25 of 34 Next >>
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 79.5 kg (174.8 pounds)
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Premarin
Dosage: unspecified
Administration route: Oral
Start date: 1992-01-01
End date: 2004-01-01
Estrogens Esterified / Methyltestosterone
Estrace
Estradiol
Dosage: unknown
Administration route: Oral
Indication: Menopausal Symptoms Prophylaxis
Start date: 1989-01-01
Other drugs received by patient: Xanax
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Medroxyprogesterone Acetate
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female, weighing 103.4 kg (227.5 pounds)
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Premarin
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 2001-04-25
End date: 2002-08-07
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2001-02-01
End date: 2001-04-09
Prometrium
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2000-12-01
End date: 2000-12-15
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2001-04-09
End date: 2002-07-26
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-22
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Cycrin
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-19
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Premarin
Dosage: unknown
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2001-01-01
Prefest
Ortho-EST
Provera
Dosage: unknown
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2001-01-01
Prempro
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-10
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Provera
Medroxyprogesterone Acetate
Premarin
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-09
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2000-12-01
Premarin
Dosage: unknown
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-09
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2000-12-01
Premarin
Dosage: unknown
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-04
Patient: female
Adverse reactions / side effects: Breast Cancer, Cardiac Disorder
Adverse event resulted in: death
Suspect drug(s):
Prempro
Medroxyprogesterone Acetate
Medroxyprogesterone Acetate
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Indication: Menopause
Premarin
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-03
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Dosage: unknown
Administration route: Oral
Start date: 1997-11-01
End date: 2001-04-01
Cycrin
Prempro
Medroxyprogesterone Acetate
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-02
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 1997-01-01
End date: 1999-11-16
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1997-01-01
End date: 1999-11-16
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-02
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic, Pulmonary Embolism
Adverse event resulted in: death
Suspect drug(s):
Prempro
Premarin
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-07-31
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Adverse event resulted in: death
Suspect drug(s):
Provera
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Premarin
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Estratest
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Estrace
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-06-29
Patient: female
Adverse reactions / side effects: Cerebrovascular Accident
Adverse event resulted in: death
Suspect drug(s):
Premarin
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-02-22
End date: 2002-06-01
Provera
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-02-22
End date: 2002-06-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-06-22
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Dosage: unknown
Start date: 1997-03-01
End date: 2000-05-01
Premarin
Dosage: unknown
Start date: 1995-06-01
End date: 1997-03-01
Provera
Dosage: unknown
Start date: 1995-06-01
End date: 1997-03-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-06-12
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Dosage: unknown
Administration route: Oral
Start date: 1983-01-01
End date: 2002-11-27
Medroxyprogesterone
Dosage: unknown
Administration route: Oral
Start date: 1983-01-01
End date: 2002-11-27
Prempro
Dosage: unknown
Administration route: Oral
Start date: 1996-01-01
End date: 1996-01-01
Adverse event in 60 year old female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-06-05
Patient: 60 year old female
Adverse reactions / side effects: Breast Cancer, Acute Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Medroxyprogesterone Acetate
Dosage: oral
Administration route: Oral
Start date: 1995-01-01
End date: 2000-01-01
Premarin
Dosage: oral
Administration route: Oral
Start date: 1995-01-01
End date: 2000-01-01
Prempro
Dosage: oral
Administration route: Oral
Start date: 2000-01-01
End date: 2003-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-05-21
Patient: female
Adverse reactions / side effects: Breast Cancer, Acute Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2003-03-01
Medroxyprogesterone
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1995-11-01
End date: 1997-01-01
Cycrin
Premarin
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1995-11-01
End date: 1997-01-01
Premarin
Dosage: unknown
Administration route: Oral
Adverse event in 61 year old female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-05-18
Patient: 61 year old female
Adverse reactions / side effects: Breast Cancer Metastatic, Oestrogen Receptor Assay Positive, Metastases TO Central Nervous System, Progesterone Receptor Assay Positive
Adverse event resulted in: death
Suspect drug(s):
Prempro
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Premarin
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-05-07
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-04-27
Patient: female, weighing 80.8 kg (177.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Prempro
Provera
Premarin
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-04-18
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-03-09
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Estrace
Indication: Hormone Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-03-08
Patient: female
Adverse reactions / side effects: Ovarian Cancer
Adverse event resulted in: death
Suspect drug(s):
Premarin (Conjugated Estrogens)
Page 1 Next >>
|
